Group 1 - The company, Suzhou Fengbei Biotechnology Co., Ltd., is a high-tech enterprise in the field of waste resource utilization, primarily producing resource-based products from waste oils [2] - The controlling shareholder and actual controller of the company is Pingyuan, who directly holds 59.78% of the shares and indirectly controls an additional 25.62% through other entities, totaling 85.40% [2] - The company plans to raise 750 million yuan for projects including the production of 300,000 tons of oleic acid methyl ester and 50,000 tons of bio-diesel, among others [2] Group 2 - The company is set to issue shares at a price of 24.49 yuan per share, with an expected total fundraising amount of approximately 879.19 million yuan [2] - After deducting issuance costs of about 84.75 million yuan, the net fundraising amount is projected to be around 794.44 million yuan [2] - The issuance will include 35.9 million shares, with 11.49 million shares available for online subscription and 20.33 million shares for offline allocation [1]

然而，电催化甘油氧化技术走向产业应用面临一大瓶颈：在工业级的大电流密度下，钴、镍等常用金属 氧化物催化剂易发生氧化非晶化，催化剂的表面像被"电糊了"一样变得松散、无序。这不仅使生产目标 产物的效率大幅下降，还浪费电能与原料。 针对这一挑战，研究团队在反应液中添加微量铜离子，在反应过程中这些铜离子能在两种价态间灵活切 换，如同一层"动态铠甲"，可有效维持催化剂表面的晶体结构，从而抑制非晶化。 经测试，铜离子的引入显著提升了甘油氧化的产物效率，在6×6平方厘米的电极下，每小时可生产13.2 克氧化产物，且能连续稳定运行超100小时，展现出大规模应用的工业化潜力。（完） 新华社北京10月21日电（记者刘祯、王莹）记者从中国科学院金属研究所获悉，该所研究团队在工业级 电流密度下电催化甘油氧化技术上取得突破，通过在反应液中添加微量铜离子，可有效解决催化剂在工 业级大电流密度下的失效难题，大幅提升产物效率与稳定性。相关论文成果21日在国际学术期刊《自 然-可持续发展》上发表。 甘油作为生物柴油产业的副产物，经氧化可升级为药物、食品、护肤品及面料的重要原料。传统的热催 化甘油氧化污染大、能耗高，而电催化甘油氧化技术以水为氧 ...

Market Overview - A-shares experienced slight fluctuations this week, with technology growth stocks performing well, as the ChiNext Index and STAR Market Index reached new highs, while the Shanghai Composite Index and Shanghai 50 Index showed sideways movement [1] - Weekly trading volume decreased to 11.57 trillion yuan, marking a six-week low due to holiday effects [1] Electronic Industry - The electronic sector attracted significant capital, with a net financing purchase exceeding 45.8 billion yuan for the week, marking the 14th consecutive week of net purchases over 10 billion yuan [2] - The electronic industry received a net inflow of over 412 billion yuan from major funds over the week, leading all sectors in net inflow [2] - Other sectors such as power equipment, telecommunications, and computers also saw substantial net purchases, while non-ferrous metals and non-bank financial sectors experienced net selling [2] Wind Power and Chemical Industries - The wind power sector showed strong performance, with the wind power equipment index rising for four consecutive days, reaching a two-and-a-half-year high [3] - The average bidding price for onshore wind turbines increased by 12.8% from 2024 to 2025, indicating a positive trend in the wind power market [3] - The chemical sector also saw collective strength, with new listings and significant price increases in various chemical products, including refrigerants and titanium dioxide [4][5] Future Outlook - Analysts expect certain chemical sub-industries to experience a phase of improvement due to ongoing policy effects, leading to healthier and more sustainable industry development [5] - The technology sector is anticipated to remain a core focus for the market, with structural opportunities expected to arise in the near future [7]

Core Viewpoint - The company, Fengbei Biological Technology Co., Ltd., is set to go public on the Shanghai Stock Exchange, aiming to raise 1 billion yuan for expansion projects in the waste oil resource utilization sector [1][3]. Financial Performance - The company has experienced declining revenue and net profit from 2022 to 2024, with revenues of 1.71 billion yuan, 1.73 billion yuan, and 1.95 billion yuan, and net profits of 135.92 million yuan, 123.04 million yuan, and 115.32 million yuan respectively, indicating a downward trend [3]. - The sales prices of the company's main products have also shown a downward trend during the same period [3][4][5]. Product Pricing - The sales prices for the company's biodiesel formulation products decreased from 0.77 million yuan/ton in 2022 to 0.61 million yuan/ton in 2024, while industrial-grade mixed oil prices fell from 0.91 million yuan/ton to 0.62 million yuan/ton [4]. - The sales prices for biofuels and oil chemical products also declined, with biofuels dropping from 0.98 million yuan/ton to 0.73 million yuan/ton, and oil chemical products from 1.18 million yuan/ton to 0.89 million yuan/ton [5]. Inventory and Liabilities - The company's inventory has been increasing, with values of 104.24 million yuan, 198.38 million yuan, and 242.01 million yuan from 2022 to 2024, indicating a growing stockpile [6]. - The raw materials, primarily waste oil and industrial-grade mixed oil, accounted for a rising proportion of total inventory, increasing from 30.77% in 2022 to 40.71% in 2024 [6]. - The company has a significant amount of current liabilities, with total current liabilities of 373.14 million yuan, 336.64 million yuan, and 358.53 million yuan over the same period, primarily consisting of short-term loans and accounts payable [7][8]. Legal Issues - The company is involved in ongoing litigation related to a fire incident at a leased facility, which resulted in significant inventory losses and subsequent lawsuits from various parties [10][11].

Group 1 - The core viewpoint of the article is that Suzhou Fengbei Biotechnology Co., Ltd. has submitted its IPO registration to the Shanghai Stock Exchange, aiming to raise approximately 750 million yuan for various projects [1] - Fengbei Biotechnology is a high-tech enterprise in the field of comprehensive utilization of waste resources, primarily producing resource-based products from waste oils [1] - The company’s IPO was accepted on June 8, 2023, entered the inquiry stage on July 5, 2023, and was approved on August 7, 2025 [1] Group 2 - The funds raised from the IPO will be invested in projects including the construction of a 300,000-ton annual production facility for methyl oleate, a 10,000-ton industrial-grade mixed oil facility, a 50,000-ton agricultural microbial agent facility, a 10,000-ton compound microbial fertilizer facility, and the production of 50,000 tons of biodiesel and 8,200 tons of glycerin as by-products [1]

Group 1 - The core viewpoint of the article is that Suzhou Fengbei Biotechnology Co., Ltd. has successfully passed the IPO review on the Shanghai Stock Exchange, indicating a positive step towards its public listing [1] - Fengbei Biotechnology is a high-tech enterprise in the field of comprehensive utilization of waste resources, primarily producing resource-based products from waste oils [1] - The company aims to raise approximately 750 million yuan through its IPO, which will be invested in various projects including the production of 300,000 tons of oleic acid methyl ester and 10,000 tons of industrial-grade mixed oil [1] Group 2 - The listing committee has requested Fengbei Biotechnology to explain the reasons and rationality behind the expected decrease or stability in sales and management expenses for 2024, despite anticipated adjustments in customer and product structures and continued revenue growth [1] - The committee also requires the company to address the authenticity of sales revenue and expenses related to industrial-grade mixed oil, considering the main operational data and performance changes for 2024 [1] - Additionally, the committee has asked Fengbei Biotechnology to assess the risks of declining biofuel revenue, the sustainability of industrial-grade mixed oil revenue growth, and the stability of the company's operating performance in light of changes in product structure and competitive advantages [2]

Group 1 - The global carbon reduction policies and environmental awareness are creating new development opportunities for the waste oil resource utilization industry [1] - Suzhou Fengbei Biological Technology Co., Ltd. (Fengbei Bio) is a representative enterprise in the domestic waste oil resource utilization field, accelerating its expansion in domestic and international markets [1] - Fengbei Bio plans to issue no more than 35.9 million shares on the Shanghai Stock Exchange, with the public offering accounting for no less than 25% of the total share capital after issuance, aiming to raise 750 million yuan for various production projects [1] Group 2 - Fengbei Bio is a high-tech enterprise in the waste resource utilization sector, primarily focusing on the resource utilization of waste oil, with a secondary emphasis on oil chemical products [2] - The company is expanding the application boundaries of waste oil resource products into various industrial fields, particularly gaining a competitive advantage in the agricultural sector [2] - The capacity expansion will achieve three strategic values: breaking existing production constraints, leveraging economies of scale to reduce marginal costs, and consolidating market leadership to strengthen competitive advantages [2]

Group 1 - The core point of the article is the upcoming review meeting by the Shanghai Stock Exchange for the initial public offering (IPO) of Suzhou Fengbei Biotechnology Co., Ltd. on August 7, 2025 [1] - Fengbei Biotechnology, established in 2014, is a high-tech enterprise in the field of waste resource utilization, focusing on the comprehensive utilization of waste oil resources [1] - The company has developed a production chain from waste oil to biodiesel and bio-based materials, supported by significant R&D investments totaling 163 million yuan from 2022 to 2024 [1] Group 2 - The company has obtained 144 patents as of March 31, 2025, and has been recognized as a national "little giant" enterprise and a unicorn cultivation enterprise in Suzhou [1] - The funds raised from the IPO will be primarily invested in expanding production capacity for biodiesel, industrial mixed oils, glycerin, agricultural microbial agents, and composite microbial fertilizers [2] - The investment projects align with national circular economy strategies and are expected to enhance the company's production capacity and market position significantly [2]

Core Viewpoint - The Shanghai Stock Exchange is set to review the IPO application of Suzhou Fengbei Biotechnology Co., Ltd. on August 7, 2025, marking a significant step for the company in the waste resource utilization sector [1] Company Summary - Suzhou Fengbei Biotechnology is a high-tech enterprise focused on the comprehensive utilization of waste resources, specifically converting waste oils into resource products [1] - The company’s IPO application was accepted on June 8, 2023, and it entered the inquiry phase on July 5, 2023 [1] - In the latest meeting materials, Fengbei Biotechnology has adjusted its fundraising projects, canceling the previously planned "supplementary working capital project," which was set to raise 250 million yuan [1] - Following the cancellation of the working capital project, the total amount intended to be raised in the IPO has been reduced to 750 million yuan, which will be allocated to several new projects, including the construction of a 300,000-ton/year oleic acid methyl ester plant, a 10,000-ton industrial mixed oil facility, a 50,000-ton agricultural microbial agent project, a 10,000-ton compound microbial fertilizer project, and the production of 50,000 tons of biodiesel and 8,200 tons of glycerol as by-products [1]

Group 1 - The Shanghai Stock Exchange will hold its 29th listing review committee meeting on August 7, 2025, to review the initial public offering (IPO) of Suzhou Fengbei Biotechnology Co., Ltd. [1] - Fengbei Biotechnology plans to issue no more than 35.90 million shares, with the public offering accounting for at least 25% of the total share capital after the issuance [1] - The company aims to raise 750 million yuan, which will be used for the construction of projects including an annual production of 300,000 tons of oleic acid methyl ester, 10,000 tons of industrial-grade mixed oil, 50,000 tons of agricultural microbial agents, 10,000 tons of compound microbial fertilizers, and by-products such as 50,000 tons of biodiesel and 8,200 tons of glycerol [1] Group 2 - The lead underwriter for this issuance is Guotai Junan Securities Co., Ltd., with representatives Hu Bo and Jin Xiang overseeing the process [1]